about
Acetylcholinesterase inhibitors: pharmacology and toxicology.Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelinesNon-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.Drugs with anticholinergic properties: a current perspective on use and safety.Neurobiology of cognitive impairment in Parkinson's disease.Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rivastigmine in Parkinson's disease dementia.
@en
type
label
Rivastigmine in Parkinson's disease dementia.
@en
prefLabel
Rivastigmine in Parkinson's disease dementia.
@en
P2860
P1476
Rivastigmine in Parkinson's disease dementia.
@en
P2093
Jayaraman Rao
Shilpa Chitnis
P2860
P304
P356
10.1517/17425250903105420
P407
P577
2009-08-01T00:00:00Z